首页> 外文期刊>The bone & joint journal. >Two-stage revision for the culture-negative infected total hip arthroplasty : A comparative study.
【24h】

Two-stage revision for the culture-negative infected total hip arthroplasty : A comparative study.

机译:培养阴性的全髋关节置换术的两阶段修订:一项比较研究。

获取原文
           

摘要

Periprosthetic joint infection (PJI) remains a challenging complication following total hip arthroplasty (THA). It is associated with high levels of morbidity, mortality and expense. Guidelines and protocols exist for the management of culture-positive patients. Managing culture-negative patients with a PJI poses a greater challenge to surgeons and the wider multidisciplinary team as clear guidance is lacking. We aimed to compare the outcomes of treatment for 50 consecutive culture-negative and 50 consecutive culture-positive patients who underwent two-stage revision THA for chronic infection with a minimum follow-up of five years. There was no significant difference in the outcomes between the two groups of patients, with a similar rate of re-infection of 6%, five years post-operatively. Culture-negative PJIs were associated with older age, smoking, referral from elsewhere and pre-operative antibiotic treatment. The samples in the culture-negative patients were negative before the first stage (aspiration), during the first-stage (implant removal) and second-stage procedures (re-implantation). Adherence to strict protocols for selecting and treating culture-negative patients with a PJI using the same two-stage revision approach that we employ for complex culture-positive PJIs is important in order to achieve control of the infection in this difficult group of patients.
机译:全髋关节置换术(THA)后,假肢周围感染(PJI)仍然是具有挑战性的并发症。它与高水平的发病率,死亡率和费用有关。存在用于培养阳性患者的指南和协议。由于缺乏明确的指导,使用PJI管理阴性的文化患者对外科医生和更广泛的多学科团队构成了更大的挑战。我们的目的是比较接受50例连续培养阴性和50例连续培养阳性的慢性感染患者的治疗效果,这些患者接受了两个阶段的THA慢性感染,且随访时间至少为5年。两组患者的转归没有显着差异,术后五年再感染率相似,为6%。培养阴性的PJI与年龄增长,吸烟,从其他地方转诊以及术前抗生素治疗有关。培养阴性患者的样本在第一阶段(抽吸)之前,第一阶段(去除植入物)和第二阶段(重新植入)过程中均为阴性。遵守严格的方案,使用与复杂的培养阳性PJI相同的两阶段修订方法选择和治疗PJI培养阴性的患者,对于控制这一困难患者群体的感染至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号